| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.55▲ | 4.55▲ | 4.53▲ | 4.52▲ | 4.75▼ |
| MA10 | 4.51▲ | 4.51▲ | 4.53▲ | 4.63▼ | 5.66▼ |
| MA20 | 4.50▲ | 4.51▲ | 4.47▲ | 4.77▼ | 6.62▼ |
| MA50 | 4.49▲ | 4.49▲ | 4.54▲ | 5.76▼ | 11.36▼ |
| MA100 | 4.47▲ | 4.59▼ | 4.75▼ | 6.84▼ | 12.72▼ |
| MA200 | 4.52▲ | 4.78▼ | 5.12▼ | 10.32▼ | 37.40▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | 0.008▲ | 0.018▲ | 0.041▲ | 0.012▲ |
| RSI | 53.408▲ | 53.394▲ | 52.114▲ | 39.424▼ | 30.328▼ |
| STOCH | 55.452 | 54.815 | 48.190 | 15.384▼ | 5.485▼ |
| WILL %R | -40.426 | -48.387 | -37.500 | -82.397▼ | -94.028▼ |
| CCI | 75.534 | 25.777 | 42.950 | -71.476 | -105.526▼ |
|
Tuesday, July 07, 2026 05:00 PM
Detailed price information for Seres Therapeutics Inc (MCRB-Q) from The Globe and Mail including charting and trades.
|
|
Thursday, February 12, 2026 05:41 AM
・Seres said the pause follows the completion of study site evaluation and qualification work with its contract research organization. ・The company said following the pause in additional investment ...
|
|
Friday, December 05, 2025 09:39 AM
The average one-year price target for Seres Therapeutics (NasdaqGS:MCRB) has been revised to $21.42 / share. This is an increase of 31.25% from the prior estimate of $16.32 dated November 14, 2025.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/08/26 | 4.51 | 4.645 | 4.39 | 4.55 | 71,766 |
| 19/08/26 | 4.44 | 4.74 | 4.375 | 4.68 | 86,948 |
| 18/08/26 | 4.44 | 4.52 | 4.315 | 4.34 | 71,280 |
| 17/08/26 | 4.55 | 4.62 | 4.45 | 4.51 | 42,124 |
| 14/08/26 | 4.51 | 4.67 | 4.44 | 4.54 | 37,237 |
| 13/08/26 | 4.75 | 4.75 | 4.46 | 4.48 | 81,430 |
| 12/08/26 | 4.63 | 4.74 | 4.585 | 4.72 | 45,244 |
| 11/08/26 | 4.94 | 4.94 | 4.615 | 4.64 | 84,273 |
| 10/08/26 | 5.05 | 5.05 | 4.78 | 5.00 | 84,081 |
| 07/08/26 | 5.07 | 5.1894 | 4.82 | 4.87 | 62,047 |
|
|
||||
|
|
||||
|
|